Kavita Parikh1, Matt Hall2, Anne J Blaschke3, Carlos G Grijalva4, Thomas V Brogan5, Mark I Neuman6, Derek J Williams7, Jeffrey S Gerber8, Adam L Hersh3, Samir S Shah9. 1. Division of Hospitalist Medicine, Department of Pediatrics, Children's National Medical Center and George Washington School of Medicine, Washington, DC. 2. Children's Hospital Association, Overland Park, Kansas. 3. Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah. 4. Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee. 5. Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington. 6. Division of Emergency Medicine, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts. 7. Division of Hospital Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt and the Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee. 8. Division of Infectious Diseases, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 9. Divisions of Hospital Medicine and Infectious Diseases, Cincinnati Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Abstract
BACKGROUND: National guidelines for the management of community-acquired pneumonia (CAP) in children were published in 2011. These guidelines discourage most diagnostic testing for outpatients, as well as repeat testing for hospitalized patients who are improving. We sought to evaluate the temporal trends in diagnostic testing associated with guideline implementation among children with CAP. METHODS: Children 1 to 18 years old who were discharged with pneumonia after emergency department (ED) evaluation or hospitalization from January 1, 2008 to June 30, 2014 at any of 32 children's hospitals participating in the Pediatric Health Information System were included. We excluded children with complex chronic conditions and those requiring intensive care or who underwent early pleural drainage. We compared use of diagnostic testing (blood culture, complete blood count [CBC], C-reactive protein [CRP], and chest radiography [CXR]) before and after release of the guidelines, and assessed for temporal trends using interrupted time series analysis. We also calculated the cost impact of these changes on diagnostic utilization and evaluated the variability of the guideline's impact across hospitals. RESULTS: Overall, 220,539 patients were included; 53% were male and the median age was 4 years (interquartile range, 2-7). For patients discharged from the ED with CAP, diagnostic utilization rates for blood culture, CBC, CRP, and CXR were higher after guideline publication compared with expected utilization rates without guidelines. In contrast, initial testing and repeat testing among patients hospitalized with CAP was lower after guideline publication. There were modest reductions in estimated costs associated with these changes. However, wide variability was observed in the impact of the guidelines across hospitals. CONCLUSIONS: Publication of national pneumonia guidelines in 2011 was associated with modest changes in diagnostic testing for children with CAP. However, the changes varied across hospitals, and the financial impact was modest. Local implementation efforts are warranted to ensure widespread guideline adherence. Journal of Hospital Medicine 2016;11:317-323.
BACKGROUND: National guidelines for the management of community-acquired pneumonia (CAP) in children were published in 2011. These guidelines discourage most diagnostic testing for outpatients, as well as repeat testing for hospitalized patients who are improving. We sought to evaluate the temporal trends in diagnostic testing associated with guideline implementation among children with CAP. METHODS:Children 1 to 18 years old who were discharged with pneumonia after emergency department (ED) evaluation or hospitalization from January 1, 2008 to June 30, 2014 at any of 32 children's hospitals participating in the Pediatric Health Information System were included. We excluded children with complex chronic conditions and those requiring intensive care or who underwent early pleural drainage. We compared use of diagnostic testing (blood culture, complete blood count [CBC], C-reactive protein [CRP], and chest radiography [CXR]) before and after release of the guidelines, and assessed for temporal trends using interrupted time series analysis. We also calculated the cost impact of these changes on diagnostic utilization and evaluated the variability of the guideline's impact across hospitals. RESULTS: Overall, 220,539 patients were included; 53% were male and the median age was 4 years (interquartile range, 2-7). For patients discharged from the ED with CAP, diagnostic utilization rates for blood culture, CBC, CRP, and CXR were higher after guideline publication compared with expected utilization rates without guidelines. In contrast, initial testing and repeat testing among patients hospitalized with CAP was lower after guideline publication. There were modest reductions in estimated costs associated with these changes. However, wide variability was observed in the impact of the guidelines across hospitals. CONCLUSIONS: Publication of national pneumonia guidelines in 2011 was associated with modest changes in diagnostic testing for children with CAP. However, the changes varied across hospitals, and the financial impact was modest. Local implementation efforts are warranted to ensure widespread guideline adherence. Journal of Hospital Medicine 2016;11:317-323.
Authors: Rachael K Ross; Adam L Hersh; Matthew P Kronman; Jason G Newland; Talene A Metjian; A Russell Localio; Theoklis E Zaoutis; Jeffrey S Gerber Journal: Clin Infect Dis Date: 2014-01-06 Impact factor: 9.079
Authors: Ricardo A Quinonez; Matthew D Garber; Alan R Schroeder; Brian K Alverson; Wendy Nickel; Jenna Goldstein; Jeffrey S Bennett; Bryan R Fine; Timothy H Hartzog; Heather S McLean; Vineeta Mittal; Rita M Pappas; Jack M Percelay; Shannon C Phillips; Mark Shen; Shawn L Ralston Journal: J Hosp Med Date: 2013-08-19 Impact factor: 2.960
Authors: Seema Jain; Derek J Williams; Sandra R Arnold; Krow Ampofo; Anna M Bramley; Carrie Reed; Chris Stockmann; Evan J Anderson; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; Anami Patel; Weston Hymas; James D Chappell; Robert A Kaufman; J Herman Kan; David Dansie; Noel Lenny; David R Hillyard; Lia M Haynes; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Richard G Wunderink; Kathryn M Edwards; Andrew T Pavia; Jonathan A McCullers; Lyn Finelli Journal: N Engl J Med Date: 2015-02-26 Impact factor: 91.245
Authors: Ross E Newman; Erin B Hedican; Joshua C Herigon; David D Williams; Arthur R Williams; Jason G Newland Journal: Pediatrics Date: 2012-02-20 Impact factor: 7.124
Authors: Mark I Neuman; Matt Hall; Adam L Hersh; Thomas V Brogan; Kavita Parikh; Jason G Newland; Anne J Blaschke; Derek J Williams; Carlos G Grijalva; Amy Tyler; Samir S Shah Journal: Pediatrics Date: 2012-10-22 Impact factor: 7.124
Authors: Derek J Williams; Samir S Shah; Angela Myers; Matthew Hall; Katherine Auger; Mary Ann Queen; Karen E Jerardi; Lauren McClain; Catherine Wiggleton; Joel S Tieder Journal: JAMA Pediatr Date: 2013-09 Impact factor: 16.193
Authors: Mark I Neuman; Matthew Hall; Susan C Lipsett; Adam L Hersh; Derek J Williams; Jeffrey S Gerber; Thomas V Brogan; Anne J Blaschke; Carlos G Grijalva; Kavita Parikh; Lilliam Ambroggio; Samir S Shah Journal: Pediatrics Date: 2017-08-23 Impact factor: 7.124
Authors: Saskia J Bogers; Frederike V van Daalen; Sacha D Kuil; Menno D de Jong; Suzanne E Geerlings Journal: Eur J Clin Microbiol Infect Dis Date: 2019-03-07 Impact factor: 3.267
Authors: Dorine Borensztajn; Joany M Zachariasse; Susanne Greber-Platzer; Claudio F Alves; Paulo Freitas; Frank J Smit; Johan van der Lei; Ewout W Steyerberg; Ian Maconochie; Henriëtte A Moll Journal: PLoS One Date: 2021-05-05 Impact factor: 3.240
Authors: Josephine S van de Maat; Daniella Garcia Perez; Gertjan J A Driessen; Anne-Marie van Wermeskerken; Frank J Smit; Jeroen G Noordzij; Gerdien Tramper-Stranders; Charlie C Obihara; Jeanine Punt; Henriette A Moll; Rianne Oostenbrink Journal: Eur J Pediatr Date: 2021-03-22 Impact factor: 3.183